The page is the record's research on the issuer — no analyst, no rating, no view. # Immunovant, Inc. (NASDAQ: IMVT) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Immunovant, Inc., listed on NASDAQ under ticker IMVT, with ISIN US45258J1025. The LEI is not on the record. The security type is Corporate. The segment is not on the record. The sector is 2836 Biological Products, (No Diagnostic Substances), and the jurisdiction is United States, Delaware. The issuer is listed and not halted. ## The disclosure read The record holds 85 filings in the window from 2025-11-08 to 2026-11-08, across 42 filing days. The median gap between filing days is 7 days. The median latency from the latest filing to the record date is 9 days. The latest filing is dated 2026-10-30 and is of type directors_dealings. The NASDAQ exchange median is 52 filings, a 6.0-day median cadence gap, and 5.0 days of median latency across 4,359 issuers. The sector median is 65.5 filings, a 5.5-day median cadence gap, and 4.0 days of median latency across 176 issuers. ## Auditor The auditor of record is Ernst & Young LLP, located in Iselin, New Jersey. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting, name change, or segment move lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is not set. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The record holds sealed years 2021, 2022, 2023, 2024, 2025, and 2026 for the issuer. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001764013.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/IMVT (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1764013/000176401326000064/imvt-20260331.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/IMVT (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/IMVT · public-record only · the same page signed and receipted: get_research at https://mcp.getissuer.ai/mcp